NCT04789668 2026-03-18Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesM.D. Anderson Cancer CenterPhase 1/2 Terminated8 enrolled 13 charts
NCT02663518 2024-05-10A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsPfizerPhase 1 Terminated249 enrolled 43 charts
NCT04272203 2022-09-08A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated CancersAbbViePhase 1 Terminated14 enrolled
NCT02706392 2022-08-31Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesFred Hutchinson Cancer CenterPhase 1 Terminated21 enrolled 19 charts
NCT02431260 2019-06-14An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated69 enrolled 34 charts